Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report ongoing study by
Infinium Global Research on the MENA tissue diagnostic market provides an in-depth
analysis of segments and sub-segments in the MENA as well as regional tissue
diagnostic market. The study also highlights the impact of drivers,
restraints, and macro indicators on the MENA and regional tissue diagnostic market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecasts, and dollar values of the MENA tissue diagnostic market. According to the report, the MENA tissue diagnostic market is
projected to grow at a significant CAGR over the forecast period of 2022-2028.
Tissues are a group of human cells
that play an important role in performing various biological functions that are
important for other healthy functions in the body. As these layers of cells
carry extremely important elements of information about the health prospects of
the body, tissue samples are commonly taken to analyze and diagnose various
health conditions, as they capture the biological specification of any disease.
Tissue diagnostic is emerging as an important field of diagnostic research as
tissue samples can explain various aspects of different biological conditions.
In the field of cancer diagnostic and analysis, tissue diagnostic has played
a vital role as it has helped scientists and researchers identify the presence
of cancer upon examining the tissue samples.
The COVID-19 pandemic had created
a significant effect on pathology diagnostic in 2020. It created a huge impact
on the healthcare provided. As the medical staff working on the frontline had
to stretch to their limits, the workload for some other healthcare workers also
had diminished. Among them were pathologists who received fewer specimens than
usual, especially during the lockdown. During a pandemic, there were multiple
concurrent clinical priorities, including the need to understand the
pathophysiology of the disease, optimize patient care, and prevention of future
infections. The COVID-19 pandemic had underpinned the central position of
diagnostic testing in outbreak control. With the continued spread of COVID-19,
rapid diagnostic tools, readily available repurposable drugs, and prompt
containment measures to control the SARS-CoV-2 infection are of paramount
importance.
The growing occurrence of cancer
across the world has caused a significant rise in the research &
development activities in the tissue diagnostic field. The high costs involved
in tissue diagnostic systems and lack of penetration are hindering the growth
of the MENA tissue diagnostic market. New Innovation in diagnostic testing
for highly efficient testing such as ISH, IHC, and FISH staining technologies
creating lucrative opportunities in the market. An increase in the number of
cancer cases, rising demand for personalized medicines among patients and
health care professionals, growing need for better diagnostic applications, and
digitalization of tissue diagnostic techniques have resulted in the improvement
of workflows and better patient care.
Among the geographies, the MENA tissue
diagnostic market is segmented into Algeria, Bahrain, Egypt, Iran, Iraq,
Israel, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, Saudi Arabia, Syria, and Tunisia, United Arab Emirates, and Yemen. Saudi Arabia accounted for the
majority of the market share of the MENA tissue diagnostic market in 2020 and
is anticipated to remain dominant throughout the forecast period. The changing
lifestyle and rising consumption of food and tobacco and increased alcohol and
common lifestyle disorders are expected to boost the market in the Middle East.
Increasing investments in new technology research and development, the
emergence of efficient and accurate products, growing demand for personalized
medicines, and untapped market potential due to a lack of efficient diagnostic tests for non-small lung cancer detection are expected to provide lucrative
opportunities for MENA tissue diagnostic market growth in this region.
The report on the MENA tissue
diagnostic market covers segments such as product, technology, and
application. On the basis of product, the sub-markets include accessories, and
instruments. On the basis of technology, the sub-markets include digital
pathology and workflow, special staining, in situ hybridization, and
immunohistochemistry. On the basis of application, the sub-markets include
non-small cell lung cancer, prostate cancer, gastric cancer, breast cancer, and
lymphoma.
The report provides profiles of
the companies in the market such as ABDULLA FOUAD group, Al Borg Medical
Laboratories, Zahrawi Group, F. Hoffmann-La Roche Ltd, Prognica Labs Tech FZCO,
Gamidor Diagnostics, Becton Dickinson & Company, Abbott, Siemens Healthcare,
and Johnson & Johnson.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors driving and restraining this market's growth. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the MENA tissue diagnostic market. Moreover, the study highlights current market trends and provides forecasts for 2022-2028. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Please Choose One of them.